GeoVax Labs, Inc. (GOVX)
1.365
+0.18
(+15.68%)
USD |
NASDAQ |
Jun 18, 16:00
1.34
-0.02
(-1.83%)
After-Hours: 19:52
GeoVax Labs Debt to Equity Ratio : 0.7991 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.7991 |
| December 31, 2025 | 0.2204 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | -0.0603 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0094 |
| December 31, 2020 | 0.0207 |
| September 30, 2020 | 0.0186 |
| June 30, 2020 | -0.3459 |
| March 31, 2020 | -0.0197 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.0252 |
| September 30, 2019 | -0.0409 |
| June 30, 2019 | -0.0337 |
| March 31, 2019 | -0.0397 |
| December 31, 2018 | -0.2935 |
| September 30, 2018 | -0.069 |
| June 30, 2018 | -0.0673 |
| March 31, 2018 | -0.3879 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.376 |
| Amgen, Inc. | 6.238 |
| BioCryst Pharmaceuticals, Inc. | -1.549 |
| Imunon, Inc. | 0.2714 |
| Curis, Inc. | 0.1052 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.982M |
| Total Liabilities (Quarterly) | 2.489M |
| Shareholders Equity (Quarterly) | 0.4938M |
| Current Ratio | 1.061 |
| Net Debt Paydown Yield | -2.03% |